Quantitative RNA & Specialty DNA Sequencing Solutions
We believe that cutting edge research shouldn’t begin with a copy.
Our mission is to enable research breakthroughs by helping customers harness the power of True Single Molecule Sequencing. Our sequencing services, sequencing equipment and bioinformatics are backed by unsurpassed customer support and uncompromising quality.
tSMS enables direct parallel sequencing of millions of individual molecules. Find out how it can address common limitations of standard sequencing technologies for quantitative RNA & specialty DNA sequencing needs.
Analyzing the differential expression of genes is a key goal of molecular biology. Find out how tSMS provides the most accurate RNA quantification available today.
Find out how tSMS is ideally suited for challenging applications where precision is paramount, quantification is needed, sample quantity is small or samples are fragmented or degraded.
Precise quantification of RNA transcripts is challenging with standard sequencing technologies as they require an amplification step. Rather than counting transcripts, these methods count copies. Since different transcripts have different amplification rates, copy counts can be distorted. SeqLL’s True Single Molecule Sequencing technology does not require amplification, so it can provide a highly accurate count of transcripts and detection of small fold changes.
Also, now available is SeqLL’s proprietary Direct RNA Sequencing technology sequencing without conversion to cDNA.
SeqLL offers a range of specialty DNA sequencing services to address your toughest challenges. With True Single Molecule Sequencing of DNA, there are fewer steps in the sequencing process, resulting in more accurate data.
After experiencing the breadth & depth of coverage from the tSMS RNA-Seq technology, it became clear that these data will progressively replace microarray-based profiling. In our human blood profiling studies, we’re getting 10 times the information, at digital precision, for a similar cost by utilizing SeqLL’s services.
Thank you, SeqLL, for continuing your outstanding support of our research by providing the best in sequencing services. As our recent publications attest, we have found that no other technology can match tSMS for high quality, publishable RNAseq findings. In addition, we appreciate the attention to detail and responsiveness that your organization provides.